Connor Clark & Lunn Investment Management Ltd. lowered its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results